The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making
Top Cited Papers
- 1 January 2004
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 20 (sup1) , S5-S26
- https://doi.org/10.1185/030079904x1980
Abstract
SUMMARYObjectives: We have developed an Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, taking into account baseline cohort characteristics and past history of complications, current and future diabetes management and concomitant medications, screening strategies and changes in physiological parameters over time. The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated.Methods: The model is based on a series of sub-models that simulate important complications of diabetes (cardiovascular disease, eye disease, hypoglycaemia, nephropathy, neuropathy, foot ulcer, amputation, stroke, ketoacidosis, lactic acidosis and mortality). Each sub-model is a Markov model using Monte Carlo simulation incorporating time, state, time-in s...Keywords
This publication has 68 references indexed in Scilit:
- UKPDS 60Stroke, 2002
- The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000Diabetes Care, 2002
- UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosisDiabetologia, 2001
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Lactic Acidosis in Patients with Diabetes Treated with MetforminNew England Journal of Medicine, 1998
- Diabetic nephropathy in type II diabetesAmerican Journal of Kidney Diseases, 1996
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991
- Probabilistic Analysis of Decision Trees Using Monte Carlo SimulationMedical Decision Making, 1986